The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …
complications affecting solid organ transplant recipients, conveying higher risks of …
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
RR Razonable, A Humar - Clinical transplantation, 2019 - Wiley Online Library
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …
outcome of solid organ transplantation. This updated guideline from the American Society of …
Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature
E Hofmann, D Sidler, S Dahdal, P Bittel… - Transplant Infectious …, 2021 - Wiley Online Library
Abstract Ganciclovir (GCV)‐resistant cytomegalovirus (CMV) infection is a common problem
among solid organ transplant (SOT) recipients without prior CMV immunity (CMV D+/R−) …
among solid organ transplant (SOT) recipients without prior CMV immunity (CMV D+/R−) …
Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients
Background Although initial therapy for cytomegalovirus (CMV) is usually successful, a
significant subset of patients may have recurrent viremia. However, the epidemiology and …
significant subset of patients may have recurrent viremia. However, the epidemiology and …
Role of secondary prophylaxis with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipients
BJ Gardiner, JK Chow, LL Price… - Clinical Infectious …, 2017 - academic.oup.com
Background Cytomegalovirus (CMV) is a major contributor to morbidity and mortality in solid
organ transplant recipients (SOTRs). Ganciclovir and valganciclovir are highly effective …
organ transplant recipients (SOTRs). Ganciclovir and valganciclovir are highly effective …
Use of letermovir for primary and secondary cytomegalovirus prophylaxis in abdominal organ transplantation: a single center experience
D Ibrahim, J Byrns, E Maziarz… - Journal of …, 2024 - journals.sagepub.com
Background: Cytomegalovirus (CMV) infection after abdominal organ transplantation is
associated with increased morbidity and mortality. The use of valganciclovir for CMV …
associated with increased morbidity and mortality. The use of valganciclovir for CMV …
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation
A Meesing, RR Razonable - Expert review of clinical pharmacology, 2018 - Taylor & Francis
Introduction: Cytomegalovirus (CMV) is a common opportunistic infection that causes
significant morbidity and preventable mortality after solid-organ and allogeneic …
significant morbidity and preventable mortality after solid-organ and allogeneic …
[HTML][HTML] Herpesvirus respiratory infections in immunocompromised patients: epidemiology, management, and outcomes
Among immunocompromised individuals, members of the human Herpesviridae family are
frequently encountered pathogens. Cytomegalovirus, herpes simplex virus 1 and 2, varicella …
frequently encountered pathogens. Cytomegalovirus, herpes simplex virus 1 and 2, varicella …
Cytomegalovirus in solid organ transplant recipients: clinical updates, challenges and future directions
RR Razonable - Current pharmaceutical design, 2020 - ingentaconnect.com
Cytomegalovirus is the classic opportunistic infection after solid organ transplantation. This
review will discuss updates and future directions in the diagnosis, prevention and treatment …
review will discuss updates and future directions in the diagnosis, prevention and treatment …
Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches
KL Hardinger, DC Brennan - Annals of Pharmacotherapy, 2024 - journals.sagepub.com
Objective: The article reviews the safety and efficacy of treatments for cytomegalovirus
(CMV) in solid organ transplantation. Data Sources: A literature review was conducted in …
(CMV) in solid organ transplantation. Data Sources: A literature review was conducted in …